Latest Breaking News On - University medical center utrecht - Page 5 : comparemela.com
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory AnginaSANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results
United-kingdomBromptonMedwayHarefieldHillingdonBelgiumCanadaUnited-statesUtrechtNetherlandsDe-hoefNoord-holland